Evaluation of intensive postremission chemotherapy for adults with acute nonlymphocytic leukemia using high-dose cytosine arabinoside with L-asparaginase and amsacrine with etoposide.
Martin S. Tallman(Memorial Sloan Kettering Cancer Center), E. Donnall Thomas(Centre d'Investigation Clinique Antilles Guyane), Rimma Goldberg(Medical Research Council), Robert B. Livingston(Active Medicine (United Kingdom)), P L Weiden, D. B. Amos(Florida College), F R Appelbaum(City Of Hope National Medical Center), Joanne Mortimer(City of Hope)
Cited by 42
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k